Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04266431 · ClinicalTrials.gov registry record · NA
EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression
A NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04266431 is a NA study that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 20 participants.
The verdict
NCT04266431, a NA study, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will evaluate whether a lifestyle intervention focused on weight loss, EMPOWER, reduces prostate cancer progression at 12 months among men with biochemical recurrence following local treatment for prostate cancer. Half of the men will be randomized to receive the EMPOWER intervention, while the other half will receive standard of care.
Interventions
- BEHAVIORAL EMPOWER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-02-20 |
| Est. Completion | 2025-02-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04266431
The ClinicalTrials.gov registry entry for NCT04266431 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EMPOWER is the first listed.
NCT04266431 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04266431 about?
NCT04266431 is a clinical study titled "EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression". This study will evaluate whether a lifestyle intervention focused on weight loss, EMPOWER, reduces prostate cancer progression at 12 months among men with biochemical recurrence following local treatment for prostate cancer. Half of the men will be randomized to receive the EMPOWER intervention, whi...
What is the current status of trial NCT04266431?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-02-20. Estimated completion is 2025-02-03.
What interventions are being tested in trial NCT04266431?
The interventions under investigation include: EMPOWER (BEHAVIORAL).
Who is sponsoring clinical trial NCT04266431?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.